http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100465229-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate | 2001-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100465229-B1 |
| titleOfInvention | Pharmaceutical compositions for angiogenesis inhibition containing 2-amino-2-deoxy-d-glucopyranose or its pharmaceutically acceptable salts |
| abstract | The present invention is for inhibiting angiogenesis comprising 2-amino-2-deoxy-D-glucopyranose (Glucosamine) or a pharmaceutically acceptable salt thereof as an active ingredient. A pharmaceutical composition, specifically a novel use of glucosamine or a pharmaceutically acceptable salt thereof currently used as a therapeutic agent for arthritis, which effectively inhibits angiogenesis and using it for the treatment of diseases related to angiogenesis. will be. Glucosamine or an pharmaceutically acceptable salt thereof having an angiogenic inhibitory effect of the present invention can be usefully used for the treatment of various diseases related to angiogenesis such as tumor suppressors, metastasis inhibitors, ocular diseases caused by angiogenesis, psoriasis, and the like. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100662903-B1 |
| priorityDate | 2001-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.